Showing results (281-290 of 388) with videos related to
Sort By:
Pageof 39
Molecular Oncology|December 16, 2024
Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibitionElena N C Schmidt, Bernd O Evert, Barbara E F Pregler, et al.Journal of Neurosurgery. Pediatrics|June 19, 2026
Incomplete tumor resection, central neuroradiological review, and second surgery in pediatric patients with intracranial ependymoma treated in the E-HIT2000 trialKara L Krajewski, Gertrud Kammler, Denise Obrecht-Sturm, et al.International Journal of Molecular Sciences|September 5, 2019
Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain TumorAlexandra Russo, Claudia Paret, Francesca Alt, et al.The Lancet. Oncology|October 26, 2010
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialEckhard Thiel, Agnieszka Korfel, Peter Martus, et al.Cancers|February 15, 2022
Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 StudyChristine Gaab, Jonas E Adolph, Stephan Tippelt, et al.Plos One|June 16, 2017
Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratificationFelipe Andreiuolo, Gwénaël Le Teuff, Mohamed Amine Bayar, et al.Cancers|June 19, 2024
Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time IrradiationJonas E Adolph, Gudrun Fleischhack, Sebastian Tschirner, et al.Journal of Neuro-Oncology|January 9, 2016
Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous systemJohannes van de Nes, Marco Gessi, Antje Sucker, et al.Neuro-Oncology|March 18, 2016
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signalingDominique Figarella-Branger, Emmanuèle Lechapt-Zalcman, Emeline Tabouret, et al.Neuro-Oncology|April 28, 2021
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trialB-Ole Juhnke, Marco Gessi, Nicolas U Gerber, et al.Pageof 39